Inhibrx Biosciences, Inc. INBX
84.52 USD +4.24 (+5.28%)
At closeNov 6, 2026, 7:29 PM EST
82.41 -2.11 -2.50%
After hours · Nov 6, 7:29 PM ET
79.47 Day range 85.57
58.39 52-week range 141.84
- YTD
- +6.99%
- 1 year
- +4.36%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.30M | 200.00K | 1.80M | 2.19M | 7.23M | |
| 1.30M | 200.00K | 1.80M | 2.19M | 7.23M | |
| -135.03M | -331.45M | -219.22M | -129.12M | -76.56M | |
| -140.06M | 1.69B | -241.36M | -145.23M | -81.77M | |
| -9.04 | 112.62 | -20.48 | -3.62 | -2.15 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 124.22M | 152.60M | 277.92M | 273.87M | 131.30M | |
| 146.48M | 180.77M | 307.89M | 290.88M | 150.45M | |
| 138.49M | 47.18M | 264.39M | 232.82M | 98.07M | |
| 107.01M | 8.05M | 210.14M | 207.10M | 77.18M | |
| 7.99M | 133.58M | 43.50M | 58.06M | 52.38M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -129.79M | -194.41M | -193.31M | -115.30M | -80.32M | |
| -28.00K | -2.60M | -4.59M | -686.00K | -809.00K | |
| 101.45M | 71.68M | 201.96M | 258.55M | 83.77M | |
| -28.00K | -2.60M | -4.59M | -686.00K | -809.00K | |
| -28.38M | -125.33M | 4.06M | 142.56M | 2.64M |